Introduction
Since the first description of an IgA protease produced by Streptococcus sanguis, several clinically important human pathogens that colonise and infect human mucosal surfaces have been reported to produce specific IgAl proteases [l] . The three leading causative agents of bacterial meningitis (Neisseria meningitidis, S. pneumoniae and Haemophilus influenzae) all produce IgA 1 proteases, whereas closely related, non-pathogenic species do not [2, 3] . Other clinically important bacteria known to produce IgAl proteases include N. gonorrhoeae, some oral streptococci and some Bacteroides and Ureaplasma spp. [1, 2] . The IgAl proteases expressed by these bacteria share the ability to hydrolyse one of the peptide bonds in a duplicated octapeptide present in the hinge region of the a1 heavy chain. As the a2 chain lacks this amino-acid sequence, it is resistant to hydrolysis by IgAl proteases. Except for the autocatalytic activity exhibited by some IgAl proteases, IgAl from man and a few other primates is the only known substrate for IgAl proteases [l] . However, the IgAl proteases constitute a structurally diverse group of molecules. The nucleotide sequences of the IgAl protease genes (iga) of N. meningitidis, N. gonorrhoeae and H. influenzae are homologous [4] and sequence for the iga gene of S. sanguis codes for a 190-kDa protein and shows no similarity to iga genes from gram-negative bacteria [8] . Furthermore, the gene fails to hybridise the chromosomal DNA from S. pneumoniae [9] .
Another way for human pathogens to interact with IgA is to express surface proteins that bind to the Fc part of IgA in a non-immune manner. Such proteins are expressed by many strains of S. pyogenes and by some strains of S. agalactiae [lo] Bacterial species expressing IgA-binding proteins do not produce IgA proteases [2] , and no IgAl proteasepositive bacteria are known to produce IgA-binding proteins of Arp or Bac type. However, bacteria that express IgA proteases and bacteria that express IgA-binding proteins are commonly found simultaneously in the upper respiratory tract [16] . Therefore, it was of interest to analyse whether these large bacterial proteins interact, as they are produced by major human pathogens. Previously reported results had shown that the bacterial IgA-binding proteins bind to purified Fcfragments produced by digestion with an IgA protease [lo, 171, but this finding did not exclude the possibility that the IgA-binding proteins might interfere with the action of IgA proteases. Furthermore, it was of interest to analyse the purified IgA-binding proteins for protease activity.
Materials and methods

IgAl proteases and IgA-binding proteins
Seven different IgAl proteases were tested: the enzymes from S. sanguis, S. pneumoniae, the type 1 and type 2 enzymes from H. injhenzae and N. meningitidis and the type 2 enzyme from N. gonorrhoeae. The proteases were purified as described previously [18] . Protein Sir, the IgA-and IgG-binding protein expressed by a group A streptococcal strain of serotype M22, was purified after expression in Escherichia coli as described previously [l 11. Protein Bac was purified from a group B streptococcal type Ib strain as described previously [ 151. Protein G (CalbiochemNovabiochem, San Diego, CA, USA), an IgG-binding protein originating from the group G streptococcus, was used as a control. The IgA used as substrate in this study was the monoclonal IgAl (Mor) protein [19] , which was '251-labelled by the chloramine-T method [20] . Proteins Sir and Bac are known to bind a majority of human monoclonal IgA proteins (ref. 11 and our unpublished data). To confirm that these proteins bind to IgAl(Mor), proteins Sir and Bac were separated by SDS-PAGE, transferred to a polyvinylidene difluoride (PVDF) membrane (Immobilon-P; Millipore Corp., Bedford, MA, USA) and incubated with '251-IgAl (Mor). Both bacterial proteins reacted strongly with the probe, whereas the IgG-binding protein G lacked reactivity in a similar way (data not shown).
IgA protease assays
The soluble phase assays were performed at room temperature with mixtures of '251-IgA, antibody binding protein, and diluted enzyme in 20 m~ Tris-buffer, pH 7.2, supplemented with 10 pM MgC12 and 10 pM CaC12 in the assays with proteases from gram-positive bacteria. To allow binding of IgA to IgA-binding protein, 15 pl of '251-IgA (0.5 pg) was pre-incubated with 15 pl of IgA-binding protein (0.6pg of Sir or 1.5pg of Bac, i.e., four-to-five-fold molar excess of IgA-binding protein), control protein (protein G, 0.6 pg) or buffer for 1 h at room temperature. After this pre-incubation, 15 p1 of enzyme in solution was added, and samples of the reaction mixture were removed at different time points. The reactions were stopped by the addition of sample buffer (SDS 2% and 2-mercaptoethanol 5%) and the samples were boiled for 5 min. The assay was performed with two incubation times and with at least two different enzyme concentrations for each enzyme. The samples were separated by SDS-PAGE in acrylamide 12% gels and the gel was dried and subjected to autoradiography and phosphor imaging (Molecular Dynamics, Sunnyvale, CA, USA) to allow quantification of radioactivity.
In the second type of assay, immobilised pre-formed complexes of IgA-binding protein and '251-IgA were digested with different IgA 1 proteases. Proteins Sir (8 pg), Bac (4 pg), G (8 pg) or '251-IgA (0.4 pg) were immobilised on a PVDF membrane, and the membranes were blocked and washed with PBS supplemented with Tween 20 0.25% and gelatin 0.25%, and incubated with 1251-IgA for 16 h at 8°C. After incubation, the membranes were washed four times for 20min each with PBS supplemented with Tween 0.25%, gelatin 0.25%, 1 M NaCl and 10 m~ EDTA. Eight identical membranes were prepared and each membrane was incubated for 5 h at room temperature with one of the seven enzymes tested, or with buffer alone. After incubation, the membranes were washed and dried, and the radioactivity was quantified by phosphor imaging.
Results
The potential interference of IgA-binding proteins with the activity of IgAl proteases was tested in a standard assay. In different experiments the incubation times and the amount of enzyme used was varied, allowing complete or only partial cleavage of the a chain. The enzymic activity of the protease was not affected by the presence of IgA-binding protein in any of these experiments. Fig. 1 shows the result of a representative experiment in which the effect of the IgA-binding proteins Sir and Bac was analysed, with the IgGbinding protein G as control. Inspection of the autoradiographs revealed no differences in the amount of cleaved fragment produced in the absence or presence of IgA-binding proteins. The amount of radioactivity in the bands representing the uncleaved and the cleaved (Y chain was quantified by phosphor imaging, and the ratio of the two values (c1eaved:uncleaved) was used as an estimate of protease activity. The results showed that the cleavage reaction was equally efficient in the presence of protein Sir, Bac or G as when buffer alone was added. Only the reaction with N. gonorrhoeae enzyme type 2 in low concentration showed a slight inhibitory effect (25% lower ratio than in control; data not shown). Similar results were In the experiment shown in Fig. 1 , IgA-binding proteins were present in a four-to-five-fold excess as compared to IgA-Fc. Since the binding of IgA to protein Sir and protein Bac is of high affinity [l 1, 151, it is unlikely that the '251-IgA digested was present in free, non-bound from. However, an experiment was also designed to analyse whether pre-formed complexes between IgA and IgA-binding proteins are sensitive to proteases. In this experiment, complexes formed on a membrane were used as the substrate (Fig. 2) . Protein Sir and protein Bac were immobilised in a row of dots on a strip of PVDF membrane. After blocking and incubation with 12'I-IgA, the sensitivity to IgAl protease of '251-IgA bound via protein Sir or protein Bac was analysed. Eight identical membrane strips were prepared and seven of these were incubated with different IgA proteases and one was incubated with buffer alone. The amount of enzyme added was expected to give 75-100% digestion of IgA in solution. After incubation, the filters were washed and dried, and the amount of radioactivity remaining in the dots was quantified by phosphor-imaging radiography. The radioactivity in the control dots (membrane incubated with buffer alone) was compared with the radioactivity in the dots on the membranes digested with various enzymes. The complexes of IgA-binding protein and IgA were sensitive to cleavage, as the amount of radioactivity was reduced on all filters incubated with enzyme, as compared to the filter incubated with buffer alone. As c. 10% of the radioactivity of the '251-IgA1(Mor) molecule is located on the Fc part [19] , cleavage of all IgA molecules would result, theoretically, in a 90% reduction of radioactivity. However, radioactivity was not reduced to this extent, which may be explained by reduced activity of the IgAl proteases close to the PVDF membrane. In an attempt to estimate the activity of the IgAl protease under the experimental conditions used in Fig. 2 , the activity of the protease on '251-IgA immobilised directly to the membrane was also determined (Fig.   2, black bars) . The H. influenzae type 1 enzyme, which was the least efficient in cleaving IgA that had bound to immobilised IgA-binding proteins, was also the least efficient in cleaving IgA immobilised directly to the membrane, suggesting that the PVDF membrane had an inhibitory effect on the protease activity. Nevertheless, the data in Fig. 2 show that a large fraction of the '251-IgA bound to IgA-binding proteins was sensitive to the action of the different IgAl proteases, which indicated that the IgA-binding proteins did not interfere with the activity of IgAl proteases.
To analyse whether the IgA-binding proteins, Sir, Arp or Bac had any IgA protease activity, these proteins were analysed in the IgA protease assay, with incubation times from 30 min to 4 h, and incubation temperatures of 37°C or 23°C. Samples were separated on SDS-PAGE and analysed by phosphor imaging as described above. In all cases, the '251-IgA used as substrate was not degraded by the presence of the IgAbinding proteins (data not shown). Furthermore, proteins Sir and Bac were shown to be resistant to the S. sanguis and H. injluenzae type 2 IgAl proteases (not shown).
Discussion
The production of IgA in man exceeds that of all other Ig classes combined [21] . 
